Capecitabine impurity 9

INQUIRY Add to cart

For Research Use Only | Not For Clinical Use

CAT	APB04191
Synonyms	(2R,3S,4R,5R)-5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-4-hydroxy-2-methyltetrahydrofuran-3-yl acetate
Molecular Weight	287.24
Molecular Formula	C11H14FN3O5

What is the synonym for Capecitabine impurity 9?

The synonym for Capecitabine impurity 9 is (2R,3S,4R,5R)-5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-4-hydroxy-2-methyltetrahydrofuran-3-yl acetate.

What is the molecular weight of Capecitabine impurity 9?

The molecular weight of Capecitabine impurity 9 is 287.24.

What is the molecular formula of Capecitabine impurity 9?

The molecular formula of Capecitabine impurity 9 is C11H14FN3O5.

What role does Capecitabine impurity 9 play in pharmaceuticals?

Capecitabine impurity 9 is a substance that may be present in pharmaceutical products as a by-product or impurity.

How is Capecitabine impurity 9 typically identified in pharmaceutical manufacturing processes?

Capecitabine impurity 9 is typically identified through various analytical techniques such as HPLC (high-performance liquid chromatography) and spectroscopy.

Are there specific regulations regarding the presence of Capecitabine impurity 9 in pharmaceutical products?

Yes, regulatory bodies often have limits on the allowable levels of impurities like Capecitabine impurity 9 in pharmaceutical products to ensure safety and efficacy.

Is Capecitabine impurity 9 harmful to humans?

The potential harm of Capecitabine impurity 9 to humans would depend on the levels present and the specific pharmacological properties of the substance.

How can pharmaceutical manufacturers reduce the levels of Capecitabine impurity 9 in their products?

Pharmaceutical manufacturers can optimize their manufacturing processes, use more purified starting materials, and implement rigorous quality control measures to reduce Capecitabine impurity 9 levels.

What are the main risks associated with the presence of impurities like Capecitabine impurity 9 in pharmaceuticals?

The main risks include potential toxicity, reduced efficacy of the drug product, and potential regulatory non-compliance.

Are there any alternative strategies to deal with Capecitabine impurity 9 in pharmaceutical manufacturing?

Alternative strategies may include modifying the synthesis route, using alternative starting materials, or developing specific purification techniques to remove Capecitabine impurity 9.

* Products or Services Interested: Capecitabine impurity 9 ()
* Your question
* Name
* Email
Verification Code

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.

Online Inquiry